| Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Numbers of shares authorized (in thousands) |
|
|
5,500,000 |
|
|
|
5,500,000 |
|
|
|
|
|
|
|
|
|
|
| Numbers of shares reserved (in thousands) |
|
|
|
|
|
|
|
|
| Employee share options |
|
|
400,000 |
|
|
|
400,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued and fully paid (in thousands) |
|
|
4,415,251 |
|
|
|
4,447,977 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital authorized |
|
$ |
55,000,000 |
|
|
$ |
55,000,000 |
|
|
$ |
1,753,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital reserved |
|
|
|
|
|
|
|
|
|
|
|
|
| Employee share options |
|
$ |
4,000,000 |
|
|
$ |
4,000,000 |
|
|
$ |
127,510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| American Depositary Receipts The Company’s ADS represents 2 ordinary shares of the Company. As of December 31, 2024 and 2025, 157,164 thousand ADSs were outstanding and represented approximately 314,328 thousand ordinary shares of the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
May be used to offset a deficit, distributed as cash dividends, or
transferred to share capital (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of ordinary shares |
|
$ |
16,519,296 |
|
|
$ |
18,000,371 |
|
|
$ |
573,809 |
|
| Merger by share exchange |
|
|
117,693,658 |
|
|
|
117,693,658 |
|
|
|
3,751,790 |
|
| Difference between consideration and the carrying amount of the subsidiaries’ net assets during actual disposal or acquisition |
|
|
3,240,987 |
|
|
|
3,172,894 |
|
|
|
101,144 |
|
| Exercised employee share options |
|
|
3,706,398 |
|
|
|
4,927,511 |
|
|
|
157,077 |
|
| Treasury share transactions |
|
|
1,059,253 |
|
|
|
1,445,560 |
|
|
|
46,081 |
|
| Donation from shareholders |
|
|
471,894 |
|
|
|
471,894 |
|
|
|
15,043 |
|
| Expired share options |
|
|
647,094 |
|
|
|
651,609 |
|
|
|
20,772 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
143,338,580 |
|
|
|
146,363,497 |
|
|
|
4,665,716 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
May be used to offset a deficit only |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Changes in percentage of ownership interest in subsidiaries (2) |
|
$ |
40,151 |
|
|
$ |
3,510,213 |
|
|
$ |
111,897 |
|
| Share of changes in capital surplus of associates accounted for using the equity method |
|
|
26,029 |
|
|
|
42,122 |
|
|
|
1,343 |
|
| Dividends that the claim period has elapsed and unclaimed by shareholders |
|
|
6,198 |
|
|
|
6,274 |
|
|
|
200 |
|
| Exercised disgorgement |
|
|
326 |
|
|
|
326 |
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72,704 |
|
|
|
3,558,935 |
|
|
|
113,450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| May not be used for any purpose |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee share options |
|
|
3,325,062 |
|
|
|
4,099,596 |
|
|
|
130,685 |
|
| Employee restricted stock awards |
|
|
1,861,744 |
|
|
|
1,364,155 |
|
|
|
43,486 |
|
| Others (3) |
|
|
119,172 |
|
|
|
915,533 |
|
|
|
29,185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,305,978 |
|
|
|
6,379,284 |
|
|
|
203,356 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
148,717,262 |
|
|
$ |
156,301,716 |
|
|
$ |
4,982,522 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
1) |
Such capital surplus may be used to offset a deficit; in addition, when the Company has no deficit, such capital surplus may be distributed as cash dividends or transferred to share capital (limited to a certain percentage of the Company’s capital surplus and once a year). |
| |
2) |
Such capital surplus arises from the effects of changes in ownership interests in subsidiaries resulting from equity transactions other than actual disposals or acquisitions, or from changes in capital surplus of subsidiaries accounted for using the equity method. |
| |
3) |
Such capital surplus represents the excess of the carrying amount of related accounts over the par value due to employee share options exercised and the Company has not completed registration formalities. |
| |
c. |
Retained earnings and dividend policy | The Articles of Incorporation of the Company (the “Articles”) provides that annual net profit shall be distributed in the following order:
| |
1) |
Replenishment of deficits; |
| |
2) |
10.0% as legal reserve; |
| |
3) |
Special reserve appropriated or reversed in accordance with laws or regulations set forth by the authorities concerned; |
| |
4) |
If annual net profit remains, a proposal for the distribution of such amount together with a part or all of the accumulated undistributed profits from previous years shall be prepared by the board of directors and submit to the shareholders’ meeting for resolution. However, the distributable dividends may be paid in cash after a resolution has been adopted by a majority vote at a meeting of the board of directors attended by two-thirds of the total number of directors; and, in addition, a report of such distribution shall be submitted to the shareholders’ meeting. | For the policies on the distribution of employees’ compensation and remuneration of directors, refer to employees’ compensation and remuneration of directors in Note 25(g). The Company is currently in the mature growth stage. To meet the capital needs for business development now and in the future and satisfy the shareholders’ demand for cash inflows, the Company shall use residual dividend policy to distribute dividends, of which the cash dividend is not lower than 30% of the total dividend distribution, with the remainder to be distributed in shares. A distribution plan is also to be made by the board of directors and submitted for resolution in the shareholders’ meeting. Appropriation of earnings to legal reserve shall be made until the legal reserve equals the Company’s share capital. Legal reserve may be used to offset deficits. If the Company has no deficit and the legal reserve has exceeded 25% of the Company’s share capital, the excess may be transferred to capital or distributed in cash. Items referred to under Rule No. 1090150022 issued by the Financial Supervisory Commission R.O.C. and in the directive titled “Questions and Answers for Special Reserves Appropriated Following Adoption of IFRS Accounting Standards” should be appropriated to or reversed from a special reserve by the Company. The appropriation of earnings for 2023 and 2024 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Appropriation of Earnings |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal reserve |
|
$ |
3,232,866 |
|
|
$ |
3,259,174 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special reserve (reversed) |
|
$ |
(167,613 |
) |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends |
|
$ |
22,838,947 |
|
|
$ |
23,420,372 |
|
|
|
$ 5.2 |
|
|
|
$ 5.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The above 2023 and 2024 appropriations for cash dividends were resolved by the Company’s board of directors in March 2024 and 2025, respectively; the other appropriations were resolved by the shareholders’ meeting in June 2024 and 2025, respectively.
| |
1) |
Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1 |
|
$ |
(5,529,388 |
) |
|
$ |
(7,034,629 |
) |
|
$ |
5,051,006 |
|
|
$ |
161,014 |
|
Recognized for the year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange differences arising on translating foreign operations |
|
|
(1,488,920 |
) |
|
|
12,101,346 |
|
|
|
(5,217,567 |
) |
|
|
(166,324) |
|
Share from associates and joint ventures accounted for using the equity method |
|
|
(16,321 |
) |
|
|
(15,711 |
) |
|
|
27,628 |
|
|
|
881 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(7,034,629 |
) |
|
$ |
5,051,006 |
|
|
$ |
(138,933 |
) |
|
$ |
(4,429 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
2) |
Unrealized gain (loss) on financial assets at FVTOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the Year Ended December 31 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1 |
|
$ |
1,275,505 |
|
|
$ |
3,549,648 |
|
|
$ |
3,730,559 |
|
|
$ |
118,921 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) recognized for the year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instruments |
|
|
(22,599 |
) |
|
|
(14,830 |
) |
|
|
(15,241 |
) |
|
|
(486 |
) |
Equity instruments |
|
|
(77,496 |
) |
|
|
(18,871 |
) |
|
|
(612,141 |
) |
|
|
(19,514 |
) |
Share from associates and joint ventures accounted for using the equity method |
|
|
2,447,656 |
|
|
|
155,784 |
|
|
|
4,352,949 |
|
|
|
138,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income for the year |
|
|
2,347,561 |
|
|
|
122,083 |
|
|
|
3,725,567 |
|
|
|
118,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative unrealized loss of equity instruments transferred to retained earnings due to disposal |
|
|
230,940 |
|
|
|
72,049 |
|
|
|
15,489 |
|
|
|
494 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative unrealized gain transferred to retained earnings due to disposal of equity instruments in relation to associates and joint venture accounted for using the equity method |
|
|
(304,358 |
) |
|
|
(13,221 |
) |
|
|
(5 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31 |
|
$ |
3,549,648 |
|
|
$ |
3,730,559 |
|
|
$ |
7,471,610 |
|
|
$ |
238,177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
3) |
Gain (loss) on hedging instruments – hedges of net investments of foreign operations |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
| |
|
For the Year Ended December 31 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1 |
|
$ |
520,281 |
|
|
$ |
277,441 |
|
|
$ |
715,703 |
|
|
$ |
22,815 |
|
Recognized for the year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk - loans denominated in foreign currency |
|
|
(242,840 |
) |
|
|
438,262 |
|
|
|
(865,379 |
) |
|
|
(27,586 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31 |
|
$ |
277,441 |
|
|
$ |
715,703 |
|
|
$ |
(149,676 |
) |
|
$ |
(4,771 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
4) |
Unearned employee benefit | In August 2021 and June 2024, the shareholders’ meeting resolved to grant restricted stock awards to employees. Refer to Note 28 for the information.
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
| |
|
For the Year Ended December 31 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1 |
|
$ |
(432,847 |
) |
|
$ |
- |
|
|
$ |
(1,631,257 |
) |
|
$ |
(52,001 |
) |
Issuance of shares |
|
|
- |
|
|
|
(1,954,312 |
) |
|
|
- |
|
|
|
- |
|
Share-based payment expenses |
|
|
11,840 |
|
|
|
395,487 |
|
|
|
1,182,815 |
|
|
|
37,705 |
|
Valuation adjustments |
|
|
421,007 |
|
|
|
(72,432 |
) |
|
|
(206,674 |
) |
|
|
(6,588 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31 |
|
$ |
- |
|
|
$ |
(1,631,257 |
) |
|
$ |
(655,116 |
) |
|
$ |
(20,884 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31, 2024 and 2025, 72,941 thousand ordinary shares of the Company were held by its subsidiaries. The Company’s ordinary shares held by its subsidiaries at each balance sheet date were as follows:
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
US$ (Note 4) |
|
|
|
|
|
US$ (Note 4) |
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASE |
|
|
67,452 |
|
|
$ |
1,762,430 |
|
|
|
|
|
|
$ |
10,927,243 |
|
|
|
|
|
|
|
|
5,489 |
|
|
|
196,677 |
|
|
|
|
|
|
|
889,281 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72,941 |
|
|
$ |
1,959,107 |
|
|
|
|
|
|
$ |
11,816,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASE |
|
|
67,452 |
|
|
$ |
1,762,430 |
|
|
$ |
56,182 |
|
|
$ |
16,896,755 |
|
|
$ |
538,628 |
|
|
|
|
5,489 |
|
|
|
196,677 |
|
|
|
6,270 |
|
|
|
1,375,092 |
|
|
|
43,835 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72,941 |
|
|
$ |
1,959,107 |
|
|
$ |
62,452 |
|
|
$ |
18,271,847 |
|
|
$ |
582,463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The aforementioned fair value is classified as Level 1 fair value with quoted prices in an active market. Under the Securities and Exchange Act in the R.O.C., the Company shall neither pledge treasury shares nor exercise shareholders’ rights on these shares, such as the rights to dividends and voting. The subsidiaries holding the aforementioned treasury shares are bestowed shareholders’ rights except the rights to participate in any share issuance for cash and voting.
|
f. |
Non-controlling interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1 |
|
$ |
18,608,124 |
|
|
$ |
20,270,547 |
|
|
$ |
22,244,661 |
|
|
$ |
709,106 |
|
Share of profit for the year |
|
|
1,849,952 |
|
|
|
1,437,974 |
|
|
|
1,180,685 |
|
|
|
37,637 |
|
Other comprehensive income (loss) for the year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange difference on translating foreign operations |
|
|
(47,301 |
) |
|
|
687,077 |
|
|
|
(58,098 |
) |
|
|
(1,852 |
) |
Unrealized gain (loss) on equity instruments at FVTOCI |
|
|
26,560 |
|
|
|
6,599 |
|
|
|
(3,354 |
) |
|
|
(107 |
) |
Gain (loss) from hedging |
|
|
(69,189 |
) |
|
|
124,336 |
|
|
|
(252,210 |
) |
|
|
(8,040 |
) |
Remeasurement on defined benefit plans |
|
|
(15,876 |
) |
|
|
3,270 |
|
|
|
14,186 |
|
|
|
452 |
|
Share in other comprehensive income (loss) from
associates accounted for using the equity method |
|
|
(7,514 |
) |
|
|
(7,157 |
) |
|
|
9,814 |
|
|
|
313 |
|
Non-controlling interests arising from acquisition of subsidiaries |
|
|
- |
|
|
|
- |
|
|
|
27,315 |
|
|
|
871 |
|
Acquisition of non-controlling interests in subsidiaries |
|
|
- |
|
|
|
- |
|
|
|
22,335 |
|
|
|
712 |
|
Decrease in non-controlling interests arising from disposal of subsidiary |
|
|
(295,895 |
) |
|
|
- |
|
|
|
(2,184 |
) |
|
|
(70 |
) |
Repurchase of outstanding shares by subsidiaries (Note 31) |
|
|
- |
|
|
|
(270,291 |
) |
|
|
(313,843 |
) |
|
|
(10,004 |
) |
Non-controlling interest arising from capital increase of subsidiaries |
|
|
427,913 |
|
|
|
177,487 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Group’s subscription for subsidiaries’ capital increase at a percentage different from its existing ownership |
|
$ |
- |
|
|
$ |
69,141 |
|
|
$ |
- |
|
|
$ |
- |
|
Cash dividends distributed to non-controlling interests |
|
|
(912,261 |
) |
|
|
(593,390 |
) |
|
|
(514,157 |
) |
|
|
(16,390 |
) |
Non-controlling interest relating to outstanding vested employee share options granted by subsidiaries |
|
|
293,740 |
|
|
|
238,183 |
|
|
|
578,048 |
|
|
|
18,427 |
|
Non-controlling interest arising from exercised convertible bonds issued by subsidiaries |
|
|
- |
|
|
|
- |
|
|
|
3,241,783 |
|
|
|
103,340 |
|
Equity component of convertible bonds issued by subsidiaries |
|
|
412,294 |
|
|
|
100,885 |
|
|
|
272,167 |
|
|
|
8,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at December 31 |
|
$ |
20,270,547 |
|
|
$ |
22,244,661 |
|
|
$ |
26,447,148 |
|
|
$ |
843,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|